ANIP ANI PHARMACEUTICALS INC Management Changes 8-K Filing 2025 - Appointments On May 22, 2025, ANI Pharmaceuticals held its Annual Meeting where stockholders approved several plans including increasing authorized shares to 66 million and amending the 2022 Stock Incentive Plan and the 2016 Employee Stock Purchase Plan. This meeting also included the election of eight directors and the ratification of EisnerAmper LLP as the independent accounting firm for 2025.Get access to all SEC 8-K filings of the ANI PHARMACEUTICALS INC